MRTX1133 is an exceptionally powerful and selective KRASG12D inhibitor. It optimally fills the switch II pocket and extends 3 substituents to favorably connect with the protein. The K And clinical trials of mixture therapy with KRAS G12C inhibitors and immune checkpoint inhibitors are presen